Aarti Drugs Limited has scheduled a Quarterly Earnings Conference Call for investors and analysts on Monday, May 18, 2026, at 11:00 AM IST. The meeting will discuss the company's financial performance for the quarter ended March 31, 2026. The intimation was filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Conference Call Details

The earnings call will feature key members of Aarti Drugs' senior leadership. The following table outlines the event schedule:

Participating Management

The following senior officials are scheduled to participate in the conference call:

• Mr. Harshit Savla – Joint Managing Director
• Mr. Harit Shah – Whole Time Director
• Mr. Adhish Patil – Chief Finance Officer & Chief Operating Officer
• Mr. Vishwa Savla – Managing Director, Pinnacle Life Science Private Limited

Dial-In Information

Investors and analysts can join the call using the following dial-in numbers:

For RSVP and further assistance, participants may contact Strategic Growth Advisors Pvt. Ltd. — Mr. Deven Dhruva or Ms. Krisha Shrimankar — at +91 98333 73300 or +91 87797 99281. The regulatory filing was signed by Rushikesh Deole, Company Secretary & Compliance Officer, on May 12, 2026.

Aarti Drugs Limited has announced the opening of a special window for re-lodgement of transfer requests of physical shares, providing an opportunity for eligible investors to complete pending share transfers. The company published newspaper advertisements on April 8, 2026, in Financial Express (English) and Pratabhkal (Marathi) to inform shareholders about this facility.

Special Window Details

The special window for transfer and dematerialisation of physical shares will remain open until February 4, 2027, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026. This facility specifically targets investors who purchased physical shares of Aarti Drugs Limited prior to April 1, 2019.

Eligibility Criteria

The facility is available for investors who fall into two specific categories:

• Investors who had not lodged their shares for transfer
• Investors who had lodged shares for transfer but the requests were rejected, returned, or not attended due to deficiencies in documentation

Applicability Matrix

The company has provided a detailed matrix to clarify eligibility for the special window:

Documentation Requirements

Only requests accompanied by original share certificates along with transfer deeds and other supporting documents will be considered under the special window. Investors must ensure they have all required original documentation before approaching the registrar.

Contact Information

Investors wishing to avail this facility should contact the company's Registrar and Transfer Agent, MUFG Intime India Private Limited (formerly Link Intime India Private Limited), located at C-101, 247 Park, LBS Marg, Vikhroli (West), Mumbai - 400083. Queries can be addressed to mt.helpdesk@in.mpms.mufg.com , and additional details are available in the SEBI Circular at www.sebi.gov.in .